Form 4 for INSM INSMED Inc
Accepted 2025-01-10 00:00:00 ET · period of report 2025-01-07 · accession 0001628280-25-001203 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-10 | 2025-01-08 | INSM | Lewis William | COB, CEO, Dir | A - Grant | — | +22.8K | 395.6K | +6% | — |
| DM | 2025-01-10 | 2025-01-07+ | INSM | Lewis William | COB, CEO, Dir | S - Sale | $65.48 | -15.2K | 392.6K | -4% | -$995.0K |
| D | 2025-01-10 | 2025-01-08 | INSM | Lewis William | COB, CEO, Dir | A - Grant | $0.00 | +109.5K | 109.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-08 | A | A | 22,824 | — | 395,567 | D | — | — | (F3) Represents RSUs, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's Amended and Restated 2019 Incentive Plan, as amended. The RSUs vest as follows: 25% on the first day of the first month following the first anniversary of the date of grant (the Initial Vesting Date) and 25% on each anniversary of the Initial Vesting Date until fully vested. (F4) Each RSU was granted on January 8, 2025 for no consideration. |
| 2 | Common | Common Stock | 2025-01-08 | S | D | 3,999 | $65.96 | 372,743 | D | — | — | |
| 3 | Common | Common Stock | 2025-01-07 | S | D | 8,218 | $66.02 | 376,742 | D | — | — | (F2) This is the weighted average sales price representing 8,218 shares sold at prices ranging from $66.00 to $66.05 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 4 | Common | Common Stock | 2025-01-10 | S | D | 2,978 | $63.36 | 392,589 | D | — | — | |
| 5 | Derivative | Stock Option (right to buy) | 2025-01-08 | A | A | 109,490 | $0.00 | 109,490 | D | $65.72 · — to 2035-01-08 | 109,490 Common Stock | (F5) These stock options were granted under the Company's Amended and Restated 2019 Incentive Plan, as amended. The options become exercisable based on the following vesting schedule: 25% vest on the Initial Vesting Date and an additional 12.5% vest every six months thereafter until fully vested. |